首页 › 黑色素瘤 › 加利福尼亚州 › San Diego
San Diego CA 黑色素瘤临床试验
18项针对 黑色素瘤的研究正在 San Diego及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
Pan-tumor MRD Study
招募中观察性研究
- Medical Oncology Associates of San Diego (MOASD), San Diego
- Medical Oncology Associates of San Diego, San Diego
Intratumoral N17350 in Advanced Solid Tumors
招募中1/2 期
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- Sharp Memorial Hospital, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- University of California, San Diego, La Jolla · 距离 11 英里
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
招募中1/2 期
- University of California-San Diego, La Jolla · 距离 11 英里
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
招募中1 期
- University of California San Diego, Moores Cancer Center, San Diego
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
招募中1/2 期
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Rady Children's Hospital - San Diego, San Diego
- Naval Medical Center -San Diego, San Diego
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
招募中2 期
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- UCSD Moores Cancer Center, La Jolla · 距离 11 英里
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
招募中1/2 期
- Research Site, La Jolla · 距离 11 英里
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
招募中观察性研究
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, La Jolla · 距离 11 英里
A Beta-only IL-2 ImmunoTherapY Study
招募中1/2 期
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
招募中1 期
- UC San Diego Moores Cancer Center, La Jolla · 距离 11 英里
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN33 项研究
- Pittsburgh, PA31 项研究
- Boston, MA26 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Columbus, OH21 项研究
- Durham, NC21 项研究
- Atlanta, GA21 项研究
- Salt Lake City, UT21 项研究
San Diego的其他研究
- 非小细胞肺癌48 项研究
- 乳腺癌41 项研究
- 癌症（所有类型）32 项研究
- 前列腺癌31 项研究
- 转移性癌症30 项研究
- 结直肠癌25 项研究
- 卵巢癌24 项研究
- 胰腺癌24 项研究
- 肺癌23 项研究
- 肥胖症23 项研究
- 心力衰竭23 项研究
- 抑郁症21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。